GlassScriptPhysician profile
Adia Kai Vernette
NPI 1073342168
$1,326.77
in general payments reported to CMS, 2019-2025
11 companies · $990 in 2025
The $990 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $337 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,326.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $342.84 | 2025 | Assure Wcd |
| Heartflow, INC. | $171.49 | 2025 | |
| Cvrx, INC. | $155.46 | 2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.97 | 2025 | Jardiance |
| Pfizer INC. | $124.11 | 2024 | |
| Abbott Laboratories | $118.91 | 2025 | Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.25 | 2024-2025 | Lifevest |
| Medtronic, INC. | $95.28 | 2024 | Corevalve Evolut R |
| Bayer Healthcare Pharmaceuticals INC. | $48.91 | 2025 | |
| Amgen INC. | $14.09 | 2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $13.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adia Vernette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.